Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes (DKDPilot)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01377688|
Recruitment Status : Completed
First Posted : June 21, 2011
Last Update Posted : June 3, 2014
We propose to pilot a telehealth approach to evaluate components of risk communication by:
- Providing personalized tailored patient feedback to help initiate and maintain specific diabetic kidney disease (DKD)-related behaviors (e.g., medication adherence, weight, exercise, diet, smoking cessation) to reduce their risks.
- Evaluating how this feedback can be incorporated into clinical care by examining 6 month patient outcomes.
Specific Aims are:
- To evaluate the feasibility and acceptability of providing both patients and their provider feedback on individuals' DKD risk via the telehealth intervention and incorporating it into regular clinical practice.
- If improvements in outcomes are found, to estimate the cost of the program in terms of the patient, provider, and overall costs of implementing the program.
|Condition or disease|
|Diabetic Kidney Disease|
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior Changes|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||April 2014|
|Actual Study Completion Date :||May 2014|
Diabetics with PKD
Diagnoses of diabetes type 2 with progressive kidney disease (slope of eGFR decline between -15 to -3 ml/min/1.73m2 per year, estimated by calculating an eGFR for each creatinine using the 4-variable Modification of Diet in Renal Disease Study [MDRD] equation and conducting a simple ordinary least squares regression from these values to evaluate changes over time to derive each individuals' slope of eGFR, annualized using test dates)
- Blood pressure and /or Estimated Glomerular Filtration Rate (eGFR) [ Time Frame: 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01377688
|United States, North Carolina|
|Duke University Health System|
|Durham, North Carolina, United States, 27705|
|Principal Investigator:||Hayden B Bosworth, PhD||Duke Universtiy Medical Center|